PA
COLL icon

Profund Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Profund Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330K Buy
9,113
+1,269
+16% +$43.4K 0.01% 746
2026
Q1 		$259K Buy
7,844
+1,323
+20% +$56K 0.01% 855
2025
Q4 		$302K Buy
6,521
+734
+13% +$30.7K 0.01% 865
2025
Q3 		$202K Buy
+5,787
New +$201K 0.01% 978
2025
Q2 		– Sell
-7,480
Closed -$223K – 1005
2025
Q1 		$223K Sell
7,480
-1,946
-21% -$59.5K 0.01% 847
2024
Q4 		$270K Buy
9,426
+1,250
+15% +$41.4K 0.01% 822
2024
Q3 		$316K Sell
8,176
-629
-7% -$22.4K 0.01% 769
2024
Q2 		$284K Buy
8,805
+3,039
+53% +$105K 0.01% 746
2024
Q1 		$224K Buy
+5,766
New +$202K 0.01% 1023

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Profund Advisors's COLL Position: Q2 2026 in Review

Profund Advisors increased its Collegium Pharmaceutical (COLL) stake by 16% in Q2 2026, buying an estimated $43.4K and bringing the position to 9,113 shares worth $330K. The position accounts for 0.01% of the portfolio, ranked #746.

Profund Advisors first reported a position in COLL in Q1 2024 and has held it in 9 quarters since. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Profund Advisors held 9,113 shares of Collegium Pharmaceutical worth $330K as of Q2 2026.
  • Profund Advisors bought 1,269 Collegium Pharmaceutical shares in Q2 2026, an estimated $43.4K.
  • Collegium Pharmaceutical made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #746 holding.
  • Profund Advisors first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 9 quarters since.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.